Unknown

Dataset Information

Glucose plus metformin compared with glucose alone on β-cell function in mouse pancreatic islets.


ABSTRACT: Metformin is currently the first drug of choice for treatment of type II diabetes. The primary function of metformin is to decrease hepatic glucose production mainly by inhibiting gluconeogenesis. The aim of the present study was to investigate the effects of glucose alone (control groups) and glucose and metformin (treatment groups) on pancreatic islets functions. Pancreatic islets were isolated by collagenase digestion and incubated for 24 or 48 h in RPMI-1640 containing 5 mmol/l glucose (control groups 1 and 2, respectively) or 24 h with 25 mmol/l glucose (control group 3) and 15 µmol/l metformin (treatment groups 1, 2 and 3, corresponding to the control groups, respectively). Subsequently, the rate of insulin output from islets, pancreatic and duodenal homeobox 1 (Pdx-1) and ins

SUBMITTER: Hashemitabar M 

PROVIDER: S-EPMC4535019 | biostudies-literature | 2015 Sep

REPOSITORIES: biostudies-literature